CAS: 123246-29-7; (S)-1-(N2-N2-((R)-2-((R)-2-((R)-2-Acetamido-3-(Naphthalen-2-yl)Propanamido)-3-(4-Chlorophenyl)Propanamido)-3-(Pyridin-3-yl)Propanoyl)-L-Seryl-L-Tyrosyl-N6-(Bis(Ethylamino)Methylene)-D-Lysyl-L-Leucyl-N6-(Bis(Ethylamino)Methylene)-L-Lysyl)-N-((R)-1-Amino-1-Oxopropan-2-yl)Pyrrolidine-2-Carboxamide, Acetate Salt
1: Sönmez Ünal G, Albak Y, Yurtcu N, Yıldız Ç, Çetin M, Durna Daştan S, Gümüş E, Çetin A. Effects of metformin and ganirelix on subcutaneous endometriosis in a mouse model of autophagy-related cell death. Turk J Obstet Gynecol. 2023 Sep 4;20(3):219-226. doi: 10.4274/tjod.galenos.2023.85616. 2: Mannaerts B. Ganirelix and the prevention of premature luteinizing hormone surges. F S Rep. 2023 Feb 24;4(2 Suppl):56-61. doi: 10.1016/j.xfre.2023.02.009. 3: Chatterjee S, Bandyopadhyay A. Synthesis and characterization of two potential impurities (des-ethyl-Ganirelix) generated in the Ganirelix manufacturing process. J Pept Sci. 2023 Sep;29(9):e3489. doi: 10.1002/psc.3489. Epub 2023 Apr 13. 35(7):427-434. doi: 10.1002/chir.23552. Epub 2023 Feb 26.